The much-anticipated retail guidance price for the national essential medicines will be officially implemented this Thursday. Yesterday, major pharmaceutical enterprises in Dongguan, including Dongguan Guoyao Group, stated that they had received notifications from the National Development and Reform Commission (NDRC) regarding the price adjustment, and would enforce relevant pricing standards for 296 kinds of medicines.
According to industry insiders, compared with the current government-specified retail guidance prices, the prices of about 45% of the drugs have been appropriately reduced, with an average price decrease of around 12%. Approximately 49% of the drugs will continue to be sold at the current prices.